AC Immune (ACIU) Treasury Shares (2020 - 2026)
AC Immune's (ACIU) quarterly Treasury Shares came in at -$278.4 million in Q1 2026, down 114712.68% year-on-year from N/an in Q1 2025, and down 2.06% on a QoQ basis from -$272.8 million in Q4 2025.
AC Immune (ACIU) Treasury Shares (2020 - 2026) Analysis & Trends
AC Immune (ACIU) has 7 years of Treasury Shares data on file, last reported at -$278.4 million in Q1 2026.
- On a quarterly basis, Treasury Shares fell 114712.68% year-over-year to -$278.4 million in Q1 2026; TTM through Mar 2026 was -$278.4 million, a 114712.68% decrease from a year earlier, with the FY2025 full-year figure at -$262.9 million, down 105559.69% from the prior year.
- Treasury Shares for Q1 2026 stood at -$278.4 million, down from -$272.8 million in the prior quarter.
- Over the last five years, Treasury Shares for ACIU reached as high as $13.6 million in Q4 2025 and fell as low as $5.9 million in Q4 2023.
- Historically, Treasury Shares has averaged $9.0 million across 5 years, with a median of $6.7 million in 2021.
- Across the five-year window, Treasury Shares jumped 100.1% in 2022 and tumbled 114712.68% in 2026, its largest moves.
- Year by year, Treasury Shares stood at $128714.7 in 2022, then plunged by 92064.79% to -$118.4 million in 2023, then soared by 99.79% to -$248851.8 in 2024, then tumbled by 109505.42% to -$272.8 million in 2025, then retreated by 2.06% to -$278.4 million in 2026.
- Per Business Quant data, the three most recent Treasury Shares figures were -$278.4 million in Q1 2026, -$272.8 million in Q4 2025, and -$272523.9 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | AC Immune | 225.68 Mn | 225.68 Mn | - | -278.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -278.39 Mn |
| Mar 31, 2026 | -278.39 Mn |
| Dec 31, 2025 | 13.64 Mn |
| Dec 31, 2025 | -272.76 Mn |
| Dec 31, 2025 | 13.64 Mn |
| Dec 31, 2025 | -272.76 Mn |
| Sep 30, 2025 | -272,523.87 |
| Sep 30, 2025 | -272,523.87 |
| Jun 30, 2025 | -263,320.07 |
| Jun 30, 2025 | -263,320.07 |
| Mar 31, 2025 | -242,470.62 |
| Mar 31, 2025 | -242,470.62 |
| Dec 31, 2024 | -248,851.76 |
| Dec 31, 2024 | 12.44 Mn |
| Dec 31, 2024 | 12.44 Mn |
| Dec 31, 2024 | -248,851.76 |
| Sep 30, 2024 | -251,617.18 |
| Sep 30, 2024 | -251,617.18 |
| Jun 30, 2024 | -241,062.98 |
| Jun 30, 2024 | -241,062.98 |